Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2000, p. 2518-2520, Vol. 44, No. 9
Microbiology Research Laboratory, Department
of Pharmacy Practice, The University of Illinois at Chicago,
Chicago, Illinois
Received 22 November 1999/Returned for modification 19 March
2000/Accepted 26 May 2000
The in vitro activity of ABT-773, a new ketolide, was compared with
those of clarithromycin, amoxicillin, metronidazole, and tetracycline
against 15 strains of Helicobacter pylori. The MIC of
ABT-773 at which 90% of isolates were inhibited was 0.25 µg/ml, which was 3 dilutions higher than that of the most active agent, clarithromycin. Synergy and antagonism were not seen with any combinations. Additive activity was seen with tetracycline,
metronidazole, and amoxicillin in 100, 60, and 40% of the
combinations, respectively.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
In Vitro Activities of a New Ketolide, ABT-773,
Alone and in Combination with Amoxicillin, Metronidazole, or
Tetracycline against Helicobacter pylori
*
Corresponding author. Mailing address: The University
of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice (M/C 886), 833 South Wood St., Chicago, IL 60612. Phone: (312)
996-8639. Fax: (312) 413-1797. E-mail: pendland{at}uic.edu.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |